203 related articles for article (PubMed ID: 23751892)
21. 8p11 myeloproliferative syndrome with t(1;8)(q25;p11.2): a case report and review of the literature.
Kim WS; Park SG; Park G; Jang SJ; Moon DS; Kang SH
Acta Haematol; 2015; 133(1):101-5. PubMed ID: 25227135
[TBL] [Abstract][Full Text] [Related]
22. 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality.
Park TS; Song J; Kim JS; Yang WI; Song S; Kim SJ; Suh B; Choi JR
Cancer Genet Cytogenet; 2008 Mar; 181(2):93-9. PubMed ID: 18295660
[TBL] [Abstract][Full Text] [Related]
23. 8p11 myeloproliferative syndrome: diagnostic challenges and pitfalls.
Antic DA; Vukovic VM; Milosevic Feenstra JD; Kralovics R; Bogdanovic AD; Dencic Fekete MS; Mihaljevic BS
J BUON; 2016; 21(3):745-9. PubMed ID: 27569099
[TBL] [Abstract][Full Text] [Related]
24. Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome.
Grand EK; Grand FH; Chase AJ; Ross FM; Corcoran MM; Oscier DG; Cross NC
Genes Chromosomes Cancer; 2004 May; 40(1):78-83. PubMed ID: 15034873
[TBL] [Abstract][Full Text] [Related]
25. Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution.
Patnaik MM; Gangat N; Knudson RA; Keefe JG; Hanson CA; Pardanani A; Ketterling RP; Tefferi A
Am J Hematol; 2010 Apr; 85(4):238-42. PubMed ID: 20143402
[TBL] [Abstract][Full Text] [Related]
26. Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder.
Oravecz-Wilson KI; Philips ST; Yilmaz OH; Ames HM; Li L; Crawford BD; Gauvin AM; Lucas PC; Sitwala K; Downing JR; Morrison SJ; Ross TS
Cancer Cell; 2009 Aug; 16(2):137-48. PubMed ID: 19647224
[TBL] [Abstract][Full Text] [Related]
27. KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32).
Levine RL; Wadleigh M; Sternberg DW; Wlodarska I; Galinsky I; Stone RM; DeAngelo DJ; Gilliland DG; Cools J
Leukemia; 2005 Jan; 19(1):27-30. PubMed ID: 15496975
[TBL] [Abstract][Full Text] [Related]
28. Identification of four new translocations involving FGFR1 in myeloid disorders.
Sohal J; Chase A; Mould S; Corcoran M; Oscier D; Iqbal S; Parker S; Welborn J; Harris RI; Martinelli G; Montefusco V; Sinclair P; Wilkins BS; van den Berg H; Vanstraelen D; Goldman JM; Cross NC
Genes Chromosomes Cancer; 2001 Oct; 32(2):155-63. PubMed ID: 11550283
[TBL] [Abstract][Full Text] [Related]
29. 8p11 myeloproliferative syndrome: a review.
Jackson CC; Medeiros LJ; Miranda RN
Hum Pathol; 2010 Apr; 41(4):461-76. PubMed ID: 20226962
[TBL] [Abstract][Full Text] [Related]
30. [8p11 myeloproliferative syndrome with CEP110-FGFR1 fusion in a patient].
Chao H; Chen S; Zhou M; Lu X; Zhang X; Pan J; Wu C; Zhang R
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Oct; 32(5):679-82. PubMed ID: 26418991
[TBL] [Abstract][Full Text] [Related]
31. Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndrome.
Malli T; Buxhofer-Ausch V; Rammer M; Erdel M; Kranewitter W; Rumpold H; Marschon R; Deutschbauer S; Simonitsch-Klupp I; Valent P; Muellner-Ammer K; Sebesta C; Birkner T; Webersinke G
Genes Chromosomes Cancer; 2016 Jan; 55(1):60-8. PubMed ID: 26391436
[TBL] [Abstract][Full Text] [Related]
32. Mutation of the AML1/RUNX1 gene in a transient myeloproliferative disorder patient with Down syndrome.
Taketani T; Taki T; Takita J; Ono R; Horikoshi Y; Kaneko Y; Sako M; Hanada R; Hongo T; Hayashi Y
Leukemia; 2002 Sep; 16(9):1866-7. PubMed ID: 12200707
[No Abstract] [Full Text] [Related]
33. The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP.
Smedley D; Hamoudi R; Clark J; Warren W; Abdul-Rauf M; Somers G; Venter D; Fagan K; Cooper C; Shipley J
Hum Mol Genet; 1998 Apr; 7(4):637-42. PubMed ID: 9499416
[TBL] [Abstract][Full Text] [Related]
34. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.
Apperley JF; Gardembas M; Melo JV; Russell-Jones R; Bain BJ; Baxter EJ; Chase A; Chessells JM; Colombat M; Dearden CE; Dimitrijevic S; Mahon FX; Marin D; Nikolova Z; Olavarria E; Silberman S; Schultheis B; Cross NC; Goldman JM
N Engl J Med; 2002 Aug; 347(7):481-7. PubMed ID: 12181402
[TBL] [Abstract][Full Text] [Related]
35. Complete response of myeloid sarcoma with FIP1L1-PDGFRA -associated myeloproliferative neoplasms to imatinib mesylate monotherapy.
Tang TC; Chang H; Chuang WY
Acta Haematol; 2012; 128(2):83-7. PubMed ID: 22722648
[TBL] [Abstract][Full Text] [Related]
36. t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature.
Wakim JJ; Tirado CA; Chen W; Collins R
Leuk Res; 2011 Sep; 35(9):e151-3. PubMed ID: 21628071
[No Abstract] [Full Text] [Related]
37. Coexistence of AML1/RUNX1 and BCR-ABL point mutations in an imatinib-resistant form of CML.
Corm S; Biggio V; Roche-Lestienne C; Laï JL; Yakoub-Agha I; Philippe N; Nicolini FE; Facon T; Preudhomme C
Leukemia; 2005 Nov; 19(11):1991-2. PubMed ID: 16151468
[No Abstract] [Full Text] [Related]
38. Molecular identification of a TPR-FGFR1 fusion transcript in an adult with myeloproliferative neoplasm, T-lymphoblastic lymphoma, and a t(1;8)(q25;p11.2).
Kim SY; Kim JE; Park S; Kim HK
Cancer Genet; 2014 Jun; 207(6):258-62. PubMed ID: 25037443
[TBL] [Abstract][Full Text] [Related]
39. A rare case report of 8p11 myeloid and lymphoid neoplasm with FGFR1 abnormality in a young adult.
Shaaban H; Dabu J; Al-Rabi K; Gauchan D; Guron G
Ann Hematol; 2013 Jan; 92(2):285-6. PubMed ID: 22941307
[No Abstract] [Full Text] [Related]
40. FIP1L1-PDGFRalpha alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib.
Wang LN; Pan Q; Fu JF; Shi JY; Jin J; Li JM; Hu J; Zhao WL; Chen Z; Chen SJ
Chin Med J (Engl); 2008 May; 121(10):867-73. PubMed ID: 18706197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
